On Tuesday shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) closed at $36.25. On May 7, Enanta Pharmaceuticals Inc. (NASDAQ:ENTA) reported fiscal second-quarter net income of $28.8 million, after reporting a loss in the same period a year earlier. The Watertown, Massachusetts-based company said it had net income of $1.49 per share.
Noble Corp plc (NYSE:NE) in last trading activity moved up 2.68% to close at $17.60. Company weekly performance is 0.00% while its quarterly performance stands at -2.35%. Noble Corp plc (NYSE:NE) is -37.21% away from its 52 week high. Noble Corp plc (NYSE:NE) announced its Board of Directors has scheduled the payment of the Company’s quarterly cash dividend of $0.375 per share payable on May 14, 2015.
On last trading day Amicus Therapeutics, Inc. (NASDAQ:FOLD) moved up 1.02% to close at $10.87. Its volatility for the week is 5.12% while volatility for the month is 5.81%. FOLD’s sales growth for past 5 years was -54.90% and its EPS growth for past 5 years was -26.20%. Amicus Therapeutics, Inc. (NASDAQ:FOLD) monthly performance is -8.66%. On May 6, it was reported that, Amicus Therapeutics, Inc. (NASDAQ:FOLD) saw its loss widen to $24.29 million, or $0.25 a share for the quarter ended Mar. 31, 2015. In the previous year period, the company reported a loss of $15.94 million, or $0.25 a share.
Sotherly Hotels Inc. (NASDAQ:SOHO) has 7.40% insider ownership while its institutional ownership stands at 45.40%. In last trading activity company’s stock closed at $8.21. Sotherly Hotels Inc. (Nasdaq:SOHO), reported its consolidated results for the first quarter ended March 31, 2015. Room revenue per available room (“RevPAR”) for the Company’s wholly-owned properties during the first quarter 2015 increased 8.3% over the first quarter 2014 to $87.87 driven by a 1.5% increase in occupancy and a 6.7% increase in average daily rate (“ADR”).
On Tuesday shares of The Boeing Company (NYSE:BA) closed at $145.43. Company’s sales growth for last 5 years was 5.90% and EPS growth for next 5 years is recorded as 12.38%. Citing steady demand from airlines, The Boeing Company (NYSE:BA) said it is capable of raising 737 jetliner output by 43 per cent to 60 a month, as it gave a rosy outlook despite concerns about orders, overall production and defence spending. Boeing Chief Executive Jim McNerney said market fundamentals that support higher jetliner production are unchanged, despite recent deferrals of aircraft deliveries by American Airlines and United Continental Holdings, which he termed normal fleet optimisation decisions.